Aspirin + Ticagrelor

DRUG3 trials

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Arkansas Heart Hospital, Petrovsky National Research Centre of Surgery

Conditions

BleedingCerebral Hypoxia During and/or Resulting From A ProcedureCoronary Artery DiseasePeripheral Arterial DiseaseThrombosis

Phase 4

Reversal of the Anti-platelet Effects of Ticagrelor

CompletedNCT02383771

The First Affiliated Hospital with Nanjing Medical UniversityCoronary Artery Disease

Start: 2015-03-31End: 2016-12-31Updated: 2017-08-16

Ticagrelor and Peripheral Arterial Disease

TerminatedNCT02407314

Arkansas Heart HospitalPeripheral Arterial Disease

Start: 2015-06-30End: 2017-01-17Updated: 2019-01-11

Unknown Phase

Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.

Active, not recruitingNCT07358416

Petrovsky National Research Centre of SurgeryBleeding, Cerebral Hypoxia During and/or Resulting From A Procedure, Thrombosis

Start: 2025-05-01End: 2026-02-28Target: 500Updated: 2026-01-22